This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Harry L. Messmore, MD; Jawed Fareed, PhD
Loyola University Medical Center Maywood, III

JAMA. 1978;240(4):345-346.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In a recent letter to the editor, Rodger L. Bick, MD, commented on methods of assay of antithrombin III (239:296, 1978), pointing out several drawbacks to the use of synthetic chromogenic substrates in such assays. His comments were prompted by an article in MEDICAL NEWS (238:1005, 1977) in which we reported that these peptides were useful in the assay of antithrombin III, emphasizing, however, that they were as yet experimental.

Since we believe that these methods are useful in the assay of antithrombin III, we have looked at the studies to which Dr Bick referred and find problems that have been successfully circumvented in these assays.

The study by Gaffney and his associates¹ showing deterioration of stored frozen thrombin is not strictly pertinent to antithrombin III assays by these methods since thrombin was shown to lose its clotting activity but not its amidolytic activity.

Autolytic forms . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?